| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |